Alnylam Claims Tekmira Infringed RNAi Tech Patents
Alnylam Pharmaceuticals Inc. filed suit Tuesday in Massachusetts federal court against Tekmira Pharmaceuticals Corp., alleging Canada-based Tekmira infringed six patents by selling gene-therapy-related molecules to pharmaceutical giant Bristol-Myers Squibb Co....To view the full article, register now.
Already a subscriber? Click here to view full article